Risk factors for death from asthma, chronic obstructive pulmonary disease, and cardiovascular disease after a hospital admission for asthma.
about
Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trialsPoor outcomes and asthma hospitalisations: How important is asthma severity and how do we measure it?Low dose inhaled corticosteroids and the prevention of death from asthma.Lack of association between ipratropium bromide and mortality in elderly patients with chronic obstructive airway diseasePsychological, social and health behaviour risk factors for deaths certified as asthma: a national case-control study.A review of anti-IgE monoclonal antibody (omalizumab) as add on therapy for severe allergic (IgE-mediated) asthmaCardiovascular morbidity and the use of inhaled bronchodilatorsA systematic review of the cardiovascular risk of inhaled anticholinergics in patients with COPD.What is severe asthma?Bronchodilator treatment and deaths from asthma: case-control study.Cost-effectiveness of omalizumab in patients with severe persistent allergic asthma.Hospitalizations and mortality in the Lung Health Study.Risk of arrhythmias associated with ipratropium bromide in children, adolescents, and young adults with asthma: a nested case-control study.
P2860
Q24613889-707C27DD-3205-40ED-8422-BF38B7576125Q33920717-15A3EB04-309C-446E-856A-85DAFBF574D2Q34342101-04ACDFB2-C372-45B9-A3C7-E3FF70F9B4A3Q35533694-6EB2B4FD-E8B5-46C0-816D-3B38B1871E18Q35564039-A62EB4FA-D433-4EE2-85C0-3F9804925DE3Q36642971-359DC0FF-CE0A-4BE9-910E-B0AEC47699E9Q36859429-DD5B3E89-219D-42D5-9AC0-FD7B3C9BFCC4Q37284894-0C6F5B71-1696-4A91-9D98-9F834611C593Q38003658-3ECDC7FC-216F-4FF3-BBD4-3604E1559A61Q40903671-C4380C68-B135-4C12-8C8A-0F20EFEF0172Q42612118-310949EB-0C2A-4DDC-9D4D-44110388EA7EQ44086880-5BC09495-FD67-4DE3-8F2A-45E7AFD46965Q51217647-0A91927D-CC28-44AE-A86E-1E14B0117DE2
P2860
Risk factors for death from asthma, chronic obstructive pulmonary disease, and cardiovascular disease after a hospital admission for asthma.
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Risk factors for death from as ...... hospital admission for asthma.
@ast
Risk factors for death from as ...... hospital admission for asthma.
@en
type
label
Risk factors for death from as ...... hospital admission for asthma.
@ast
Risk factors for death from as ...... hospital admission for asthma.
@en
prefLabel
Risk factors for death from as ...... hospital admission for asthma.
@ast
Risk factors for death from as ...... hospital admission for asthma.
@en
P2860
P356
P1433
P1476
Risk factors for death from as ...... hospital admission for asthma
@en
P2093
P2860
P304
P356
10.1136/THX.54.4.301
P407
P50
P577
1999-04-01T00:00:00Z